Shukra Pharmaceuticals Profit & Loss Annual

BSE: 524632 | NSE: - | ISIN: INE551C01028 | Sector: Biotechnology & Drugs

60.64 +1.74 (2.95%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	74.57	58.83	20.49	11.20
Total Revenue	74.57	58.83	20.49	11.20
Costof Revenue Total	44.49	45.32	10.35	2.77
Gross Profit	30.09	13.52	10.14	8.43
Selling/ General/ Admin Expenses Total	5.65	4.89	4.90	4.07
Depreciation/ Amortization	2.05	1.84	1.66	1.47
Other Operating Expenses Total	5.04	3.26	2.35	2.92
Total Operating Expense	57.22	55.31	19.26	11.42
Operating Income	17.35	3.53	1.22	-0.23
Interest Inc( Exp) Net- Non- Op Total	-2.85	-2.56	-2.81	-0.13
Other Net	2.82	1.17	0.08	0.34
Net Income Before Taxes	19.88	4.44	1.02	0.10
Provisionfor Income Taxes	1.35	0.04	0.27	-0.09
Net Income After Taxes	18.54	4.41	0.75	0.19
Net Income Before Extra Items	18.54	4.41	0.75	0.19
Net Income	18.54	4.41	0.75	0.19
Income Availableto Com Excl Extra Ord	18.54	4.41	0.75	0.19
Income Availableto Com Incl Extra Ord	18.54	4.41	0.75	0.19
Diluted Net Income	18.54	4.41	0.75	0.19
Diluted Weighted Average Shares	4.38	0.67	3.01	3.01
Diluted EPS Excluding Extra Ord Items	4.23	6.55	0.25	0.06
DPS- Common Stock Primary Issue	1.00	0.13	0.03	0.00
Diluted Normalized EPS	4.23	6.55	0.25	0.10
Total Adjustmentsto Net Income	-	0.00	-	-
Unusual Expense( Income)	-	-	-	0.20